Novo Will Work With Anthropic AI to Speed Drug Development

Novo Nordisk and Anthropic have entered a partnership to accelerate drug development using AI. For Novo, this is a key task in competing in the obesity drug market.

• Novo Nordisk and Anthropic announced partnership
• Goal is to accelerate drug development with AI
• For Novo, it's a way to catch up in obesity market